Ancient DNA is telling us more and more about humans and environments long past. Could it also help rescue the future?

According to China's plan for circular economy development during the 14th Five-Year Plan (2021-2025) period, by 2025, the ...

At an incineration power plant in north China\'s Tianjin Municipality, garbage trucks unload waste that is left to ferment for five to seven days before being incinerated to generate electricity, ...

Following bone fracture in mice, Park et al. demonstrated mobilization of these cells ... Intercept, Johnson and Johnson, Novo Nordisk, and Shire. His institution receives grant funding from Pharmaxis ...

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...

Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s dominance over the weight-loss industry. The Danish pharma giant ...

Competition from Him & Hers Health seems to be weighing on Novo Nordisk's stock. A half-hearted rating from Morgan Stanley yesterday isn't cheering investors up very much at all. Yet a new study ...

Novo Nordisk announced phase 1b/2a clinical trial results for amycretin this morning. Patients taking the GLP-1 drug lost an average of 9.7% of their weight in 36 weeks. This is the best news Novo ...

Novo Nordisk (NYSE: NVO) stock is in a funk. Shares of the GLP-1 diet drug manufacturer have been sliding all week long, beginning with a 3% decline on Monday from last Friday's close, and falling ...

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it gave to pharmacy firms, obesity charities and other professional bodies ...

Last week, Novo Nordisk released its year-end results, including how it performed over the last three months of 2024. Net sales for the quarter totaled 85.7 billion Danish kroner ($12 billion) and ...